B

BALZA E.

Last name: BALZA E.

1992 (v1)

Publication

Metadata-only

Tenascin and fibronectin distribution in human normal and pathological synovium.

CUTOLO, MAURIZIO Picasso M Ponassi M

No description

Uploaded on: March 31, 2023
2019 (v1)

Publication

Metadata-only

L19-IL2 immunocytokine in combination with the anti-syndecan-1 46F2SIP antibody format: A new targeted treatment approach in an ovarian carcinoma model

Orecchia P. Balza E. Pietra G.

Epithelial ovarian cancer (EOC) is the fifth most common cancer affecting the female population. At present, different targeted treatment approaches may improve currently employed therapies leading either to the delay of tumor recurrence or to disease stabilization. In this study we show that syndecan-1 (SDC1) and tumor angiogenic-associated...

Uploaded on: April 14, 2023
2020 (v1)

Publication

Metadata-only

The Elusive Link Between Cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in Diabetes

Cossu V. Bauckneht M. Bruno S.

This study aims to verify in experimental models of hyperglycemia induced by streptozotocin (STZ-DM) to what degree the high competition between unlabeled glucose and metformin (MET) treatment might affect the accuracy of cancer FDG imaging. The study included 36 "control" and 36 "STZ-DM" Balb/c mice, undergoing intraperitoneal injection of...

Uploaded on: April 14, 2023